Results 141 to 150 of about 7,624 (217)

Chemokine-chemokine receptor networks in conventional type I dendritic cells: an opportunity to prime and boost anticancer immunity. [PDF]

J Pharmacol Exp Ther
Kuo N, Shinn CK, Schokrpur S, Idoyaga J, Handel T, Gutkind JS.   +5 more
europepmc   +1 more source

CD11c-Cre driven deletion of <i>Irf8</i> reveals the effect of somatic mosaicism in a mouse model of SLE. [PDF]

Front Immunol
Wang H, Qi CF, Scott B, Kole H, Bolland S.   +4 more
europepmc   +1 more source

Tumors located in the brain impair the frequency and phenotype of dendritic cells in blood and tumor. [PDF]

iScience
Gardam B, Gargett T, Nam E, Khan S, Ormsby RJ, Poonnoose SI, Bracken JM, Pasam A, Lenin S, Gliddon BL, Tea MN, Shard CL, Pitson SM, Gomez GA, Pillman KA, Sandhu S, Brown MP, Ebert LM.   +17 more
europepmc   +1 more source

Nano-Luciferase complementation assay of human herpesvirus 8 chemo/cytokine-receptor interactions. [PDF]

Sci Rep
Palande V, Roden RBS, Choi YB.
europepmc   +1 more source

Lactococcus lactis-HSP65 requires TLR2 to induce tolerogenic dendritic cells and confer protection against type 1 diabetes in a murine model. [PDF]

Cell Mol Life Sci
Elias-Oliveira J, Rodrigues VF, Pereira ÍS, Barbosa SC, Pereira JA, Pacheco TCF, Machado MSG, Masson AP, Rios WM, Gardinassi LG, Miyoshi A, Azevedo V, Silva CL, Tostes RC, Carlos D.   +14 more
europepmc   +1 more source

158P XCR1+ dendritic cell (DC) role in antitumoral response to anti PD-L1 antibody: Data from the phase Ib/II trial of DC vaccination in small cell lung cancer patients

Immuno-Oncology and Technology
M. Cao, M. Sistere, M.T. Moran Bueno, N. Reguart, A. Meyerhans, R. Cabezón, A. A. Hernandez, R. Roman, M. Molina-vila, K. Birgin, E. Domenjo, G. Pique, J. Sabaté, I. Sullivan, I. M. Horno, L. Cirera, A. Drozdowskyj, R. Rosell, M. Juan, D. Benítez-Ribas   +19 more
semanticscholar   +1 more source

Expression and function of the chemokine receptor XCR1 on murine CD8 + DC

, 2010
In dieser Arbeit wurde die Expression von XCR1 in B6XCR1lacZ+/+ Reporter Mäusen charakterisiert, die β-Galaktosidase unter der Kontrolle des XCR1-Promotors exprimieren. In Gewebeschnitten konnten wir zeigen, dass eine starke XCR1-Expression nur in lymphatischen Organen wie Milz, Lymphknoten und Thymus nachweisbar ist.
openaire   +1 more source

Flt3L-mediated tumor cDC1 expansion enhances immunotherapy by priming stem-like CD8⁺ T cells in lymph nodes. [PDF]

Nat Immunol
Lai J, Chan CW, Armitage JD, Audsley KM, Huang YK, Derrick EB, Carstensen LS, Scheffler CM, Jones ME, Sek K, Principe N, Kim JS, House IG, Chen AXY, Yap KM, Middelburg J, Munoz I, Nguyen D, Tong J, Hoang TX, Todd KL, Evrard M, Chee J, Mackay LK, Forrest ARR, Parish IA, Bosco A, Waithman J, Beavis PA, Darcy PK.   +29 more
europepmc   +1 more source

Spatial Organisation of Tumour cDC1 States Correlates with Effector and Stem-Like CD8⁺ T Cells Location. [PDF]

Eur J Immunol
Piot C, Pereira da Costa M, Biram A, Minutti CM, Lim KHJ, Green M, Mikolajczak A, Jenkins RP, Meader L, Buck MD, Cardoso A, Rogers N, Sahai E, Reis E Sousa C.   +13 more
europepmc   +1 more source

Identifying Chemokine System-Related Phenotype to Predict Immune Feature in Pan-Cancer and Prognostic Signature for Lung Adenocarcinoma. [PDF]

J Inflamm Res
Zhao T, Wu X, Guo S, Nie J, Fang S, Wang L, Li X, Nie T, Yao K, Du X, Wang Y, Yuan Y, Ni J.   +12 more
europepmc   +1 more source